These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1901511)

  • 1. Difference in label length between demethylchlortetracycline and oxytetracycline: implications for the interpretation of bone histomorphometric data.
    Parfitt AM; Foldes J; Villanueva AR; Shih MS
    Calcif Tissue Int; 1991 Feb; 48(2):74-7. PubMed ID: 1901511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The label escape error: comparison of measured and theoretical fraction of total bone-trabecular surface covered by single label in normals and patients with osteoporosis.
    Keshawarz NM; Recker RR
    Bone; 1986; 7(2):83-7. PubMed ID: 3087397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone formation periods studied with triple tetracycline labels in women with postmenopausal osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Apr; 8(4):443-50. PubMed ID: 8475794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women.
    Balena R; Shih MS; Parfitt AM
    J Bone Miner Res; 1992 Dec; 7(12):1475-82. PubMed ID: 1481733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The label escape error: determination of the active bone-forming surface in histologic sections of bone measured by tetracycline double labels.
    Schwartz MP; Recker RR
    Metab Bone Dis Relat Res; 1982; 4(4):237-41. PubMed ID: 7182723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ANTIBACTERIAL ACTIVITY OF TETRACYCLINES IN RELATION TO ITS FIXATION IN OSSEOUS TISSUE].
    PATANIA S; DECRISTOFARO R; VIRGA G
    Arch Ortop; 1963; 76():115-9. PubMed ID: 14180421
    [No Abstract]   [Full Text] [Related]  

  • 8. TOXICITIES ASSOCIATED WITH TETRACYCLINE THERAPY.
    PFLUG GR
    Am J Pharm Sci Support Public Health; 1963 Dec; 135():438-50. PubMed ID: 14101403
    [No Abstract]   [Full Text] [Related]  

  • 9. The bone biopsy protocol for evaluating osteoporosis and osteomalacia.
    Vigorita VJ
    Am J Surg Pathol; 1984 Dec; 8(12):925-30. PubMed ID: 6393777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do different fluorochrome labels give equivalent histomorphometric information?
    Sun TC; Mori S; Roper J; Brown C; Hooser T; Burr DB
    Bone; 1992; 13(6):443-6. PubMed ID: 1476823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the mineralization front: comparison of a modified toluidine blue stain with tetracycline fluorescence.
    Villanueva AR; Kujawa M; Mathews CH; Parfitt AM
    Metab Bone Dis Relat Res; 1983-1984; 5(1):41-5. PubMed ID: 6200748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetracycline labeling of bone in vivo.
    Tam CS; Anderson W
    Calcif Tissue Int; 1980; 30(2):121-5. PubMed ID: 6155183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females.
    Recker RR; Kimmel DB; Parfitt AM; Davies KM; Keshawarz N; Hinders S
    J Bone Miner Res; 1988 Apr; 3(2):133-44. PubMed ID: 3213608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the location of osteoblastic alkaline phosphatase activity and bone formation in human iliac crest bone.
    Bradbeer JN; Zanelli JM; Lindsay PC; Pearson J; Reeve J
    J Bone Miner Res; 1992 Aug; 7(8):905-12. PubMed ID: 1442204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A classification of in vivo bone labels after double labeling in canine bones.
    Hori M; Takahashi H; Konno T; Inoue J; Haba T
    Bone; 1985; 6(3):147-54. PubMed ID: 4027093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
    Recker RR; Delmas PD; Halse J; Reid IR; Boonen S; García-Hernandez PA; Supronik J; Lewiecki EM; Ochoa L; Miller P; Hu H; Mesenbrink P; Hartl F; Gasser J; Eriksen EF
    J Bone Miner Res; 2008 Jan; 23(1):6-16. PubMed ID: 17892374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in quantitative bone histomorphometry in aging healthy men.
    Clarke BL; Ebeling PR; Jones JD; Wahner HW; O'Fallon WM; Riggs BL; Fitzpatrick LA
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2264-70. PubMed ID: 8964862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [INVESTIGATIONS ON THE QUESTION OF CROSS RESISTANCE OF TETRACYCLINE, OXYTETRACYCLINE, CHLORTETRACYCLINE AND DEMETHYLCHLORTETRACYCLINE TO 40 STRAINS OF STAPHYLOCOCCI].
    BREITFELLNER G; NEUHOLD R
    Chemotherapia (Basel); 1964; 64():30-40. PubMed ID: 14178042
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of cortical and trabecular bone formation in the long bones of immobilized monkeys.
    Wronski TJ; Morey ER
    Clin Orthop Relat Res; 1983 Dec; (181):269-76. PubMed ID: 6416730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro sensitivity of various pathogenic organisms to the 4 tetracyclines demethylchlortetracycline, chlortetracycline, oxytetracycline and tetracycline].
    MALAMOS B; DAIKOS GK; KOURKOUMELI P; PARADELIS A
    Z Mikrosk Anat Forsch; 1960; 146():544-7. PubMed ID: 13765692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.